dc.contributor.author | James, ND | |
dc.contributor.author | Spears, MR | |
dc.contributor.author | Clarke, NW | |
dc.contributor.author | Dearnaley, DP | |
dc.contributor.author | De Bono, JS | |
dc.contributor.author | Gale, J | |
dc.contributor.author | Hetherington, J | |
dc.contributor.author | Hoskin, PJ | |
dc.contributor.author | Jones, RJ | |
dc.contributor.author | Laing, R | |
dc.contributor.author | Lester, JF | |
dc.contributor.author | McLaren, D | |
dc.contributor.author | Parker, CC | |
dc.contributor.author | Parmar, MKB | |
dc.contributor.author | Ritchie, AWS | |
dc.contributor.author | Russell, JM | |
dc.contributor.author | Strebel, RT | |
dc.contributor.author | Thalmann, GN | |
dc.contributor.author | Mason, MD | |
dc.contributor.author | Sydes, MR | |
dc.date.accessioned | 2020-08-24T10:08:29Z | |
dc.date.issued | 2015-06-01 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353808900016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier.citation | EUROPEAN UROLOGY, 2015, 67 (6), pp. 1028 - 1038 | |
dc.identifier.issn | 0302-2838 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4000 | |
dc.identifier.eissn | 1873-7560 | |
dc.identifier.doi | 10.1016/j.eururo.2014.09.032 | |
dc.format.extent | 1028 - 1038 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Elsevier BV | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Prostate cancer | |
dc.subject | Natural history | |
dc.subject | Survival | |
dc.subject | Time to progression | |
dc.subject | Control arm cohort | |
dc.subject | Hormone-naive | |
dc.subject | Metastatic | |
dc.subject | Prognostic factors | |
dc.subject | Prospective data | |
dc.title | Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era'': Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019) | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1016/j.eururo.2014.09.032 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2015-06 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | EUROPEAN UROLOGY | |
pubs.issue | 6 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Prostate and Bladder Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley) | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Prostate and Bladder Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 67 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Prostate Cancer Targeted Therapy Group | |
icr.researchteam | Clinical Academic Radiotherapy (Dearnaley) | |
icr.researchteam | Prostate and Bladder Cancer Research | |
dc.contributor.icrauthor | James, Nicholas | |
dc.contributor.icrauthor | Dearnaley, David | |
dc.contributor.icrauthor | De Bono, Johann | |